Clinicoecon Outcomes Res. 2014 Mar 18;6:125-31. doi: 10.2147/CEOR.S59194. eCollection 2014.

Comparative cost effectiveness of Coflex® interlaminar stabilization versus instrumented posterolateral lumbar fusion for the treatment of lumbar spinal stenosis and spondylolisthesis.

ClinicoEconomics and outcomes research : CEOR

Jordana Kate Schmier, Marci Halevi, Greg Maislin, Kevin Ong

PMID: 24672250 PMCID: PMC3964032 DOI: 10.2147/CEOR.S59194

Abstract

INTRODUCTION: Symptomatic chronic low back and leg pain resulting from lumbar spinal stenosis is expensive to treat and manage. A randomized, controlled, multicenter US Food and Drug Administration Investigational Device Exemption clinical trial assessed treatment-related patient outcomes comparing the Coflex® Interlaminar Stabilization Device, an interlaminar stabilization implant inserted following decompressive surgical laminotomy in the lumbar spine, to instrumented posterolateral fusion among patients with moderate to severe spinal stenosis. This study uses patient-reported outcomes and clinical events from the trial along with costs and expected resource utilization to determine cost effectiveness.

METHODS: A decision-analytic model compared outcomes over 5 years. Clinical input parameters were derived from the trial. Oswestry Disability Index scores were converted to utilities. Treatment patterns over 5 years were estimated based on claims analyses and expert opinion. A third-party payer perspective was used; costs (in $US 2013) and outcomes were discounted at 3% annually. Sensitivity analyses examined the influence of key parameters. Analyses were conducted using Medicare payment rates and typical commercial reimbursements.

RESULTS: Five-year costs were lower for patients implanted with Coflex compared to those undergoing fusion. Average Medicare payments over 5 years were estimated at $15,182 for Coflex compared to $26,863 for the fusion control, a difference of $11,681. Mean quality-adjusted life years were higher for Coflex patients compared to controls (3.02 vs 2.97). Results indicate that patients implanted with the Coflex device derive more utility, on average, than those treated with fusion, but at substantially lower costs. The cost advantage was greater when evaluating commercial insurance payments. Subgroup analyses found that the cost advantage for Coflex relative to fusion was even larger for two-level procedures compared to one-level procedures.

CONCLUSION: The Coflex Interlaminar Stabilization Device was found to be cost effective compared to instrumented posterolateral fusion for treatment of lumbar spinal stenosis. It provided higher utility at substantially lower cost.

Keywords: cost analysis; spine; treatment comparison

References

1. Spine (Phila Pa 1976). 2013 Aug 15;38(18):1529-39 - PubMed
2. J Bone Joint Surg Am. 2013 Aug 21;95(16):1450-6 - PubMed
3. J Spinal Disord Tech. 2007 May;20(3):255-61 - PubMed
4. Spine (Phila Pa 1976). 2009 Sep 1;34(19):2085-9 - PubMed
5. Spine J. 2010 Jul;10(7):588-94 - PubMed
6. Spine (Phila Pa 1976). 2000 May 1;25(9):1132-9 - PubMed
7. JAMA. 2010 Apr 7;303(13):1259-65 - PubMed
8. Spine (Phila Pa 1976). 1997 May 15;22(10):1123-31 - PubMed
9. J Neurosurg Spine. 2013 Aug;19(2):174-84 - PubMed
10. Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952 - PubMed
11. Rheumatology (Oxford). 2000 Jul;39(7):783-90 - PubMed
12. Spine (Phila Pa 1976). 2011 Nov 15;36(24):2061-8 - PubMed
13. Spine J. 2009 Jul;9(7):545-50 - PubMed

Publication Types

• Journal Article